98.5% Purity 151096 -09-2 Moxifloxacine

Model NO.
151096-09-2
Specification
98.5%
Trademark
blue lake
Origin
Jiangxi China
Production Capacity
60 Tons Per Month
Reference Price
Please contact us for quote
Contact Us

Product Description

PART A: Medicine Description
Moxifloxacin  is an  antibiotic , used to treat  bacterial infections ,  including  pneumonia ,  conjunctivitis ,  endocarditis ,  tuberculosis , and  sinusitis .  It can be given by mouth, by  injection into a vein , and as an  eye drop .


PART B: Medicine Functions
Moxifloxacin treats a number of infections, including respiratory-tract infections, cellulitis, anthrax, intra-abdominal infections, endocarditis, meningitis, and tuberculosis.
In the United States, moxifloxacin is licensed for the treatment of acute bacterial sinusitis, acute bacterial exacerbation of chronic bronchitis, community-acquired pneumonia, complicated and uncomplicated infections of the skin and of the skin structure, and complicated intra-abdominal infections.In the European Union, it is licensed for acute bacterial exacerbations of chronic bronchitis, non-severe community-acquired pneumonia, and acute bacterial sinusitis.

98.5% Purity 151096-09-2 Moxifloxacine

Property Name Property Value Reference
Molecular Weight 401.4 Computed by PubChem 2.1 (PubChem release 2023.05.07)
XLogP3-AA 0.6 Computed by XLogP3 3.0 (PubChem release 2023.05.07)
Hydrogen Bond Donor Count 2 Computed by Cactvs 3.4.8.18 (PubChem release 2023.05.07)
Hydrogen Bond Acceptor Count 8 Computed by Cactvs 3.4.8.18 (PubChem release 2023.05.07)
Rotatable Bond Count 4 Computed by Cactvs 3.4.8.18 (PubChem release 2023.05.07)
Exact Mass 401.17508442 Computed by PubChem 2.1 (PubChem release 2023.05.07)
Monoisotopic Mass 401.17508442 Computed by PubChem 2.1 (PubChem release 2023.05.07)
Heavy Atom Count 29 Computed by PubChem
Complexity 727 Computed by Cactvs 3.4.8.18 (PubChem release 2023.05.07)
Isotope Atom Count 0 Computed by PubChem
Defined Atom Stereocenter Count 2 Computed by PubChem
Undefined Atom Stereocenter Count 0 Computed by PubChem
Defined Bond Stereocenter Count 0 Computed by PubChem
Undefined Bond Stereocenter Count 0 Computed by PubChem
Covalently-Bonded Unit Count 1 Computed by PubChem
Compound Is Canonicalized Yes Computed by PubChem (release 2023.05.07)

 

PART  C: Company Profile

98.5% Purity 151096-09-2 Moxifloxacine
98.5% Purity 151096-09-2 Moxifloxacine 98.5% Purity 151096-09-2 Moxifloxacine 98.5% Purity 151096-09-2 Moxifloxacine 98.5% Purity 151096-09-2 Moxifloxacine
 
PART  D : Contact Information
Website: 
 
 
 



 











 

 

Pharmaceutical Chemicals

LEGALIS.IT, 2023